Latest Industry Insights

In this interview, discover how Astoriom's Integrated Stability & Sustainability Outsourcing Model addresses traditional storage challenges and enables biopharma companies to respond more nimbly to disruptions.

Anti-infective discovery is evolving with AI and robotics – learn how UK researchers aim to cut development time and improve success rates.

Today, single-cell technologies are not only dissecting genomic, transcriptomic and proteomic profiles but also enabling dynamic measurements of cellular functions. Bruker's new Beacon Discovery Platform could make this a reality for more labs.

Learn how CD34+ stem cells may help heart attack patients recover. A look at cutting-edge cell therapies and what's coming next in cardiac care.

Discover how induced pluripotent stem cell technology is solving scale and consistency issues in mesenchymal stem/stromal cell therapy manufacturing and learn about Cynata’s ongoing clinical trials.

James Connelly discusses the importance of third-party verification and how recent funding will help accelerate the development of Impact Laboratories' digital sustainability tools.

Portal Bio’s microfluidic technology enhances drug discovery and cell engineering by enabling efficient, scalable molecular delivery for sensitive cell types.

In this interview, Technology Networks spoke with Dr. Francesco Dell’Accio and Dr. Suzanne Eldridge to explore the impact of osteoarthritis on patients, the goals of ReFleks and a novel approach to repairing osteochondral defects.

To explore how the CGT landscape is evolving, Technology Networks spoke with Betty Woo, vice president of Cell, Gene and Advanced Therapies at Thermo Fisher Scientific.

The limitations of traditional cryopreservation are becoming increasingly apparent. In this interview, Alastair Carrington, CEO of Atelerix, explores how hypothermic preservation technology is transforming biopreservation.